The Two Prices of an Ankle Sprain
Ankle sprains come at a price. In fact, they have two.
Talk to a public health researcher and you’ll hear about volume — millions of injuries a year, a slow grind of urgent care visits and missed workdays that adds up to billions of dollars annually. Talk to a sports franchise and you’ll hear about something else entirely: a single player, a persistently troublesome ankle, and a number large enough to threaten a season.
Same injury. Two completely different economics. Understanding both is the starting point for understanding why LigaSys exists.
The Public Health Number
In the United States, roughly 2 million ankle sprains are reported every year, making it one of the most common musculoskeletal injuries in the nation. Emergency department charges for ankle injuries alone exceed a billion dollars annually, and direct management costs — treatment, imaging, follow-up care — typically run several hundred to a few thousand dollars per patient, depending on severity. When you fold in lost productivity and time away from work and community, total impact estimates push toward the higher end of several billion dollars a year.
That number alone would justify attention. But it understates the real cost, because ankle sprains have a habit of not staying healed. Somewhere between 40 and 75 percent of sprains progress to chronic ankle instability —a lingering vulnerability that turns a single injury into a recurring one. The first sprain is rarely the expensive one. The fifth one is.
The Elite Sports Number
Now zoom into a single professional roster.
Ankle sprains are the most common injury in basketball and one of the most common in soccer. For one max-contract athlete, a single multi-week absence — 11 consecutive missed games — cost his team millions of dollars in salary paid for zero in-game return. Run similar math against any top-of-market contract and the per-game cost of a single absence lands in the hundreds of thousands of dollars PER GAME.
And that’s only the cost that shows up on payroll. It doesn’t capture standings position, playoff seeding, or home game advantage lost while a star sits. It doesn’t capture the ticket sales, the in-arena spend, or the broadcast ratings of a marquee game played without the player fans bought tickets to see. And it doesn’t capture the slow-building risk to a guaranteed high-value contract, when a single joint becomes a recurring liability over years rather than weeks.
The injury that costs a public health system a several hundred dollars and the injury that costs a franchise eight figures over a season are, biomechanically, the same event. The stakes just scale with who’s affected.
Why This Matters
It would be easy to treat these as two different problems. In practice, that’s largely what’s happened.
Most products built for everyday athletes — braces, compression wear, consumer wearables — are sold directly to consumers, optimized for price and accessibility rather than elite-level quality. Meanwhile, most technology built for institutional sports is analytical, not protective: motion tracking and load management platforms that help teams understand fatigue, workload, and injury risk after the fact, without doing anything to intervene in the moment an injury is actually happening. Plenty of products measure. Almost none respond.
The underlying problem doesn’t care which side of the gap you’re standing on. A joint that can be injured faster than the body can protect itself is the same biomechanical event whether it happens to a recreational athlete or a professional one.
That’s the problem LigaSys is building Smart Ligament™ systems to address — starting at the ankle, and starting with the sports where the cost of getting it wrong is most immediate.
